Director/PDMR Shareholding

RNS Number : 1997O
Reckitt Benckiser Group PLC
30 September 2019
 

 

 

 

 

30 September 2019

 

 

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

 

Notification of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

The Company received notification on 27 September 2019 that on 26 September 2019 the following Directors/PDMRs acquired shares through participation in the Company's Dividend Reinvestment Plan:

 

Name

Director / PDMR

Number of Shares Acquired

Price per Share

Mary Harris

Director

25

£65.5739

Rob De Groot

PDMR

129

£65.5739

Aditya Sehgal

PDMR

962

£65.5739

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mary Harris

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

GBP 65.5739

25

 

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price

Aggregate Volume

Aggregate Total

GBP 65.5739

25

GBP 1,639.34

e)

Date of the transaction

 2019-09-26

f)

Place of the transaction

London Stock Exchange, Main Market - XLON

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob De Groot

2

Reason for the notification

a)

Position/status

President, Hygiene Home

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Acquisition of Shares through participation in the Company's  Dividend Reinvestment Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

GBP 65.5739

129

 

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price

Aggregate Volume

Aggregate Total

GBP 65.5739

129

GBP 8,459.03

e)

Date of the transaction

 2019-09-26

f)

Place of the transaction

London Stock Exchange, Main Market - XLON

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Aditya Sehgal

2

Reason for the notification

a)

Position/status

Chief Operating Officer, Health

b)

Initial notification/
Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Acquisition of Shares through participation in the Company's Dividend Reinvestment Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

GBP 65.5739

962

 

d)

Aggregated information

-       Aggregated volume

-       Price

Aggregate Price

Aggregate Volume

Aggregate Total

GBP 65.5739

962

GBP 63,082.09

e)

Date of the transaction

 2019-09-26

f)

Place of the transaction

London Stock Exchange, Main Market - XLON

 

 

Contact:

Christine Logan

Deputy Company Secretary

Reckitt Benckiser Group plc

01753 217800

 

103-105 Bath Road, Slough SL1 3UH

Registered in England and Wales, No. 06270876 

 

About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

 

For more information visit www.rb.com

 

 *RB is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSGDCGBXBGCG
UK 100

Latest directors dealings